Sigilon Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sigilon Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q2 2023.
  • Sigilon Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $7.06M, a 34.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $7.06M -$3.76M -34.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $8.03M -$3.68M -31.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $8.98M -$3.88M -30.2% Dec 31, 2022 10-Q 2023-08-07
Q3 2022 $9.91M -$4.66M -32% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $10.8M -$4.11M -27.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $11.7M -$4.39M -27.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $12.9M -$3.87M -23.1% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $14.6M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $14.9M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $16.1M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $16.7M Dec 31, 2020 10-K 2022-03-14
Q3 2019 $1.7M Sep 30, 2019 10-K 2023-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.